cDNA Cloning Demonstrates the Expression of Pregnancy-Specific Glycoprotein Genes, a Subgroup of the Carcinoembryonic Antigen Gene Family, in Fetal Liver by Zimmermann, Wolfgang et al.
Vol. 163, No. 3, 1989 
September 29, 1989 
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
Pages 1197-1209 
cDNA CLONING DEMONSTRATES THE EXPRESSION OF PREGNANCY-SPECIFIC 
GLYCOPROTEIN GENES, A SUBGROUP OF THE CARCINOEMBRYONIC ANTIGEN GENE 
FAMILY, IN FETAL LIVER 
Wolfgang Zimmermann, Martina Weiss and John A. Thompson 
Institute of Immunobiology of the University of Freiburg, 
Stefan-Meier-Str. 8, D-7800 Freiburg, FRG 
Received August 9, 1989 
Summary: The pregnancy-specific glycoprotein (PSG) genes constitute a subgroup of the carcinoembryonic antigen 
(CBA) gene family. Here we report the cloning of four cDNAs coding for different members of the PSG family from a 
human fetal liver cDNA library. They are derived from three closely related genes (PSGl, PSG4 and PSGL). Two of the 
cDNA clones represent splice variants of PSGl (PSGl, PSGl,) differing in their C-terminal domain and 3’wtranslated 
regions. All encoded proteins show the same domain arrangement (N-R,,,-R,-R&Z). Transcripts of the genea PSGl and 
PSG4 could be detected in placenta by hybridization with genespecific oligonucleotides. Expression of cDNA in a mouse 
and monkey cell line shows that the glycosylated PSGl, protein has a M, of 65-66 kD and is released from the transfected 
cells. Sequence comparisons in the C-terminal domain and the 3’-untranslated regions of CBA/PSG-like genes suggests 
a complex splicing pattern to exist for various gene family members and a common evolutionary origin of these regions. 
Q 1989 Academic Press, hc. 
The carcinoembryonic antigen (CEA) is a human tumor marker of great significance in clinical 
oncology. Although CEA lacks absolute tumor specificity (I), its serum levels are used to moni- 
tor the success of therapy mainly for adenocarcinomas of the colon, breast and lung (2). The 
CEA gene is the prototype of a larger gene family which can be subdivided into the CEA and 
the pregnancy specific glycoprotein (PSG) subgroups (3). So far 14 CEA- and PSG- like genes 
have been identified, some of them only by partial genomic sequences (3-19). All members of 
the CEA family belong to the immunoglobulin superfamily and are composed of one variable 
(V) and a varying number (2, 3 or 6) of constant (C) domains (3,20-22). The in vivo function of 
CEA- and PSG-like antigens is unknown, although recent experiments indicate, that CEA might 
play a role in cell adhesion (23). 
CEA- and PSG-like antigens comprise a heterogenous group of glycoproteins (for a review see 
24; 25,26). PSG-like antigens are synthesized in the placenta and accumulate in large amounts in 
maternal serum during pregnancy (27,28). Furthermore, these antigens have been discussed as 
potential markers for tumors of trophoblastic origin (29). Expression of CEA-like genes has 
been shown for a number of normal and cancerous tissues. Transcripts of the CEA and/or of 
the non-specific crossreacting antigen (NCA) gene have been identified in tumors of the colon, 
breast, pancreas, gall bladder and lung and in normal colonic mucosa (30,31). The biliary glyco- 
protein I (BGP I) gene is transcribed in normal liver and in various tumor cell lines (13,14). In 
Abb~vlatiostat CBA, carcinoembryonic antigen; NCA, notqxific crossreacting antigen; BGP I, biliary glycoprotein I; 
PSG, pregnanq-specific glycoprotein; DMEM, Dulbecco’s modified Eagle’s medium; SDS, sodium dodecylaulfate; 
DOTMA, N-[l-(2,3dioleyloxy)proI@]-N,N,N-trimethylammonium chloride; SPl, Schwangerschaftsprotein 1. 
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contrast, not much is known about the expression of CEA- and PSG-like genes during fetal 
development, except that CEA is found in a variety of fetal tissues (32-34). 
In order to identify other members of the CEL4 gene family which are expressed during human 
development, we decided to screen cDNA libraries derived from human fetal tissues for the 
presence of CEA/PSG-like cDNA clones. Such clones would allow delineation of the complete 
primary structures for members of the CEA family as well as helping to study their function 
during embryogenesis and tumor development. 
MATERIALS AND METHODS 
Cell lines and tissues: The human choriocarcinoma cell line BeWo (American Type culture collection ATCC CCL 98) 
and the SV40 transformed African green monkey kidney cells COS7 (ATCC CRL 1651) were propagated in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with penicillin, streptomycin and 15% or 10% fetal calf serum, 
respectively. The human colonic tumor was propagated in nude mice (35). The human tissues were immediately frozen in 
liquid nitrogen and stored at -140 “C until use. 
Screening of the cDNA library: The PSG cDNA clones were isolated from a fti trimester fetal liver cDNA library 
(Clontech, Palo Alto, USA) by screening the lambda gtll recombinant phages with a mixture of CBA and NCA cDNA 
probes from pCEA1 (4), pCE!A5 and pNCA1 (36). The cDNA inserts of these plasmids comprise part of the sequences 
coding for the N-terminal domains of CEA and NCA and repeated domains of CEA. Hybridization of the phage DNAs 
on nitrocellulose filters (Schleicher and Schuell, Dassel, FRG) was performed in the presence of 40% formamide, 5x 
Denhardt’s solution (lx = 0.02% each of Ficoll (Pharmacia, Freiburg, FRG), polyvinyl pyrrolidon, bovine serum albumin 
(fraaion V, Serva, Heidelberg, FRG)), 6x SSPE (lx = 0.18 M NaCl, 10 mM sodium phosphate pH 7.4, 1 mM EDTA), 
0.5% sodium dodecylsulfate (SDS) and 100 rg/ml heat-denatured salmon sperm DNA at 37 “C over night. After a Fmal 
wash at 65 “C in lx SSPE, 0.1% SDS for 30 minutes the filters were exposed to X-ray films. Positive plaques were 
isolated and some of them plaque-purified twice (37). 
DNA sequencing and sequence analysis: The cDNAs were sequenced after subcloning into Bluescript (Stratagene, La 
Jolla, USA) or Ml3 vectors as double or single strands according to Sanger (38) using universal or internal oligonuo 
leotide primers. The 17 mer oligonucleotide primers were synthesized and purified as described before (36). For compa- 
rison of the nucleotide and amino acid sequences the computer programs “Align” (M Trippel and R. Friedrlch, unpub- 
lished) and “Dot Matrix” (Rechenzentrum der Universittit Freiburg) were used. 
Expression of PSCl, cDNA in mouse 3T3 cells 
Construction of pBEH/PSGl; The full length cDNA of PSGl, was excised from the vector by digestion with EcoRI and 
cloned into the expression vector pBEHpUC9 (39) downstream of the SV40 early promoter. First, the 1.3 kb EcoRI 
cDNA fragment containing the coding region of PSGl, was cloned into the vector. The correct orientation of the insert 
was demonstrated by digestion w&h SmaI (Fig. 4A). The plasmid with the correctly oriented EcoRI fragment was then 
partially digested with EcoRI, the linearized recombinant plasmid was recovered from the low melting point agarose gel 
after separation of the DNA fragments by electrophoresis and ligated to the 0.6 kb EcoRI fragment of PSGl,. Among 
the clones obtained pBEH/PSGl, was identified as the expression vector construct with the corred 3’-location and 
orientation of the 0.6 kb EcoRI cDNA fragment by yielding fragments of expected size after double digestion with SmaI 
and SpeI (Fig. 4A). 
Stable transfection of pBEH/PSGl, into 3T3 cells: Stable transfectants were obtained using the recently described 
lipofection technique (40). OS-l.0 x lo6 NIH 3T3 cells were seeded in a 75 cm plastic culture dish in DMEM supple- 
mented with 10% fetal calf serum, penicillin and streptomycin. 24 hours later the cells were washed three times with 
DMEM without serum and treated with 2Q rg of DOTMA (a gift from Phil Felgner, Syntex Research, Palo Alto, USA), 
1 rg of the plasmid pSV2neo (41), which confers resistance toward the neomycin-derivative G418 and a tenfold molar 
excess (10 rg) of the PSGl, expression construct pBEH/PSGl, in 3 ml of DMEM without serum. Control cultures were 
only transfected with 1 pg of pSV2neo DNA. After 24 hours 10 ml of DMEM/lO% fetal calf serum were added and 72 
hours later selection for cells expressing the bacterial neo gene was started by addition of 1 mg/ml of the antibiotic G418 
(GIBCO-BRL, Karlsruhe, FRG). After three weeks 100-300 large colonies were visible. They were harvested by tryp 
sinization and used as a mixture for metabolic labeling experiments. 
Metabolic labeling and immunoprecipitation of PSGl, protein: 
Half confluent cultures of the transfectants in 75 cm culture dishes were incubated with [US]methionlne (specific 
radioactivity > loo0 Ci/mmole) at 170 &i/ml in 1.5 ml of methioninefree DMEM/lO% dialyzed fetal calf serum at 37 
“C. After incubation for 7 hours the medium was chilled on ice, adjusted to 1 mM dithiorhreitol, 1 mM phenymethyl- 
sulfonyl fluoride, 0.01% aprotinin (Sigma Chemie, Deisenhofen, FRG) and a tenfold excess of methionine to that 
normally present in DMEM, centrifuged for 1 minute at 12,000xg and stored at -70 “C. One third of the supematant was 
incubated over night at 4 “C with 5 mg protein A-Sepharose (Pharmacia, Freiburg, FRG) saturated with the immune- 
globulin fraction of a rabbit anti-human pregnancy-specific gl glycoprotein (PS#lG) or synonymously, “Schwangerschafts- 
protein 1” (SPl) antiserum (DAKO, Copenhagen, Denmark) either in the presence or absence of 10 fig of purified SP1 
(a gift from H. Bohn, Behringwerke, Marburg, FRG). The immunoprecipitaks were washed three times with 0.5 rr~I Of 
buffer J (10 niM T&Cl pH 7.5, 140 mM NaCl, 1 mM dlrhiothritol, 0.01% aprotinin, 0.1% SDS, 1% NP-40, 1% dmv- 
cholate), once with 10 mM T&Cl pH 7.5 and subjected to electrophoresis on a 10% polyacrylamide gel containing 0.1% 
SDS (42). For fluorography, the gel was soaked with Enlightning (NEN Research Products, Dreieich, FRG) for 30 
minutes, dried and exposed to X-ray film for 40 hrs. 
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RNA blot hybridization: Total RNA was extracted from fresh 5eWo cells or in liquid nitrogen pulverized tissues by the 
guanidinium thiocyanate method (43) or alternatively, by a method according to Chomczynski and Sacchi (44). Poly(A)+ 
RNA was isolated by one or in the case of colon tumors by two rounds of chromatography on oligo(dP) cellulose. (Sigma 
Chemie, Deisenhofen, PRG) according to Aviv and Leder (45). Size fractionation of the RNAs on aharose gels in the 
presence of methyhnercuty hydroxide, transfer to charged nylon membranes and hybridization with [ PIlabeled cDNA 
fragments (46) was performed as described recently (30). When genespecilic [UP]labeled oligonucleotides (specific 
radioactivity: 0.4-1.0~1~ dpm/rg) were used as probes (Table I) the formamide concentration was lowered from 50% to 
O-20%, depending on the calculated melting point of the hybrid (47), which was 10-U “C above the hybridization 
temperature. After hybridization, the RNA blots were washed twice in 2xSSPE at room temperature for 10 minutes and 
once in 6xSSPE, 1% SDS for 60 minutes at a temperature where only hybrids with a maximum of one mismatch are 
stable. 
RESULTS 
Isolation and analysis of pregnancy-specific glycoprotein cDNA clones. For the isolation of 
CEA/PSG-like cDNA clones from a fetal liver cDNA library, lti plaques were hybridized with 
probes comprising coding regions of CEA and NCA cDNAs (for details see Materials and 
Methods). The applied hybridization conditions allowed cross-hybridization with members of all 
known subgroups of the CEA gene family, whose N-terminal domain exons reveal between 67 
and 95% similarity at the nucleotide level (3). From the 150 positive clones seven were selected 
for further analysis. Digestion with restriction endonucleases and partial sequence analysis 
hPSGla 
BarnHI 
EC ORI 
5’ 3 A PSGld 
hPSG4 
APSGG 
R 1: Domein strwhne and aaquendug strateey of PSGl, P5G1, PSGI and PSG6. The cDNAs were sequenced 
to the Stratw indicated hy arrows. OnIy the AM recognition sites relevant for sequencing are shown. The 
fl$k@ EcoRl sifes have “” created hy the cloning procedure The codii regions can be subdh$led into a leader Ir;l, 
-tmmmal or variable domam lhrj, hahmpzat or constant domains lILti& and Gtenninal domam [c]. Lambda PSG4 
is an in%n@cte clone and the dashed lines indlcate the complete strucunc as derived from an overta@l cDNA clone 
published ekwltere (16). 
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indicated that these clones are derived from four different mRNAs. Four of these clones, 
lambda PSGl,, lambda PSGl,, lambda PSG4 and lambda PSG6 were completely sequenced 
according to the strategy shown in Fig. 1. The cDNA inserts of the clones lambda PSGl, and 
lambda PSGl, share a common sequence from their S-end downstream to position 1243 but 
differ completely beyond this point (Fig. 2). This indicates, that the corresponding mRNAs are 
derived from the same gene by differential splicing. On the other hand, the sequences of the 
cDNA inserts of lambda PSG4 and lambda PSG6, although very similar, differ from each other 
and from the PSGl clones. They are, therefore, derived from two other closely related genes. All 
P!SGla 
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Figure 2: Continued 
clones except lambda PSG6 cover the 3’-ends of the corresponding mRNAs because of the 
presence of polyadenylation signals and an oligo(A) stretch in the case of lambda PSGl,. The 
mRNAs represented by lambda PSGl, and lambda PSGl, encode preproteins of 419 (M, 47,217; 
minus leader: 43,473) and 426 amino acids (M, 47,860; minus leader: 44,116), respectively. They 
differ only in their C-terminal domains consisting of 5 and 12 amino acids, respectively (Fig. 2). 
Lambda PSG6 cDNA contains one long open reading frame of 435 amino acids (M, 48,813; 
minus leader: 45,137) whereas the cDNA insert of lambda PSG4 is truncated at the S-end. In 
comparison to the domain structure of CEA and NCA (24) the coding regions of lambda PSGl,, 
and lambda PSG6 are found to be composed of the following sequence of domains: a leader (34 
amino acids), an N-terminal or immunoglobulin V-like domain of 110 and 109 amino acids, 
respectively, and three half repeats or immunoglobulin C-like domains (22), two of which belong 
to the A-type (RAIN, 92 amino acids) and one to the B-type (R, 85 amino acids) (16). The 
open reading frame of lambda PSG4 cDNA shows the same domain organization, however, the 
N-terminal domain and most of the R,, domain is missing (Fig. 1). In lambda PSG4 and lambda 
PSG6 R, is followed by a short C-terminal domain with lengths of 5 and 22 amino acids, respec- 
tively. Except for lambda PSGl, and lambda PSG4 the C-terminal domains and 3’-untranslated 
regions seem to be unrelated (Fig. 2). The open reading frames of all four clones contain 
multiple, potential N-glycosylation sites (PSGl: 7; PSG4: 6; PSG6: 7) most at conserved posi- 
tions, suggesting that the encoded proteins are highly glycosylated as is known for other mem- 
bers of the CEA family (for review see 24). In addition, the N-terminal domain of PSG6 con- 
tains the amino acid sequence RGD (Fig. 2) which is found in many extracellular matrix pro- 
teins, where it is known to convey cell adhesion (48). Comparison of the nucleotide sequences of 
the various domains of PSGl,, PSG4 and PSG6 with the corresponding sequences of members 
of the CEA and PSG subgroups reveal degrees of similarity which clearly indicates that the 
members of the CEA family belong to the PSG subgroup. Furthermore, PSGl,, PSG4 and 
PSG6 correspond to genomic clones which have recently been partially sequenced (PQG, 
hsCGM4 and hsCGM3, respectively [3]). 
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Table I; Gene- and splice variant-specific oligonucleotides. Olionucleotides complementary to the corres- 
ponding mRNAs have been synthesized and purified as described before (2) 
oligonucleotide sequence 5’-3# position reference 
PSGl CTAGTCCCATCATCTCCCTTTATG 
‘PSGl 
372 
PSGl: 
GTCTTGCTCTTAGTGATTCCATGG 1292 
CTTATAGGGCTTCAGAGACTTCGA 1298 26 
PSG-C CAATGGACCATGTAGGCTGTCTTC 1605 15 
PSG4 GTGACTTGGGCAGTTGTGGGCGGA 490 b3 
PSGC AGTATAAGGTGACAGTGAAATATC 454 
* In the 3’-untranslated region of PSG4 the homologous region contains the same sequence except for one 
mismatch. Therefore, cross-hybridization of olio PSGl, with F’SG4 mRNA cannot be ruled out. 
b Sequence was derived from clone hsCGM4. 
Northern blot analyses. To characterize the sizes of the transcripts derived from the three PSG 
genes and to investigate whether these genes are active in tissues other than fetal liver, Northern 
blot experiments were performed. To be able to discriminate the mRNAs of these very closely 
related genes from each other as well as from the CEA subgroup, geile-specific oligonucleotides 
were used (Table I). Their sequences were selected from the N-terminal domains, where se- 
quence information for most of the CEA gene family members is available. Hybridization with 
a rP]labeled oligonucleotide specific for PSGl detected two transcripts of 2.0 and 2.2 kb in 
RNA from a 31 week human placenta (Fig. 3A,B; lane 1) whereas three transcripts of 1.8, 2.0 
and 2.2 kb were found with a PSG4-specific oligonucleotide (Fig. 3B, lane 7). No transcripts 
could be identified for PSG6 in placenta, although the oligonucleotide used for this analysis 
hybridized in a control experiment with the corresponding genomic clone lambda hsCGM3 (3; 
data not shown). Although the presence of PSG in choriocarcinomas has been reported (for a 
review see [56]) none of the PSG subgroup members seems to be transcriptionally active in a 
oligo oligo oligo oligo 
PSGl PSGla PSGld NCA PSGl PSGla PSG4 
PC PC PCPC PC PC PC PC PC 
A B 
- 2.8kb 
- 1.8kb 
12 34 56 78 910 1 2 345678 
3: AmIysis of PSG gene transcripts. 2 pg of poiy(A)-mntaining RNA from a 31 week placenta (P) or a colonic 
YzE+) wexc size-fraaionated on a 1% agarose gel in the prcwnce of methylmercwy hydroxide, transfered to a nylon- 
membrane and hybridized with [pp]labeled oligonuckotides (see Table I) specific for PSGl tmnscr@s (A,B lanes 1,Z) or 
for the PSGl, splice variant (A lanes 3,4), for PSG4 mRNA (B lane 7&) or with the BunHI-ECORI cDNA fragment 
covering the Y-nom.mding region of PSGl, under low stringmey conditions (wash in 2xSSPE, 60 ‘c; A lane 5.6). As a 
control a NCA-spe&?c probe (the 1.4 kb EcoRl fragment of clone 9 containing the 3’-untranslated region [lo]) was used 
to prove the intactness of the colon hlmor RNA, which contains NCA mRNA. Crowhybridization of the NCA and the 
PSGl, probe (the 670 bp E&U cDNA fragment covering the 3’-untranslated repion) is observed with the 2.2 kb PSGl 
and the 2.8 kb NC4 transcript, respectively, under low stringency conditions (A lane 7; B lane 4), which is abolished 
after stringent washing (A lane 9; B lane 6). 
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choriocarcinoma cell line (BeWo), as demonstrated by hybridization under nonstringent condi- 
tions with the coding region of PSGl, (the 1.3 kb EcoRI fragment of lambda PSGl,). In addi- 
tion, neither of these PSG genes seems to be expressed in colon tumors (Fig. 3B, lanes 2, S), 
where, however, transcripts of members of the CEA gene subgroup, namely NCA (Fig. 3A, lanes 
8, 10) and CEA (30) are found. Inversely, the 2.8 kb NCA mRNA could not be detected in 
placental RNA Fig. 3A, lane 9). However, under nonstringent conditions with the probe cover- 
ing the 3’-untranslated region of the NCA mRNA (10) a 2.2 kb mRNA species was visualized 
(Fig. 3A, lane 7). This cross-hybridization is probably due to the sequence similarity within the 
3’-nontranslated region of the NCA and some of the PSG mRNAs (Fig. 5). 
Together with PSGl, and PSGl,, described here, four different splice variants of the PSGl gene 
have been identified by cDNA cloning (15,16,19,26). In order to assign the 2.0 kb and 2.2 kb 
PSGl mRNA species to individual splice variants, cDNA fragments from the 3’-untranslated 
regions of PSGl, and PSGl, and oligonucleotides specific for the splice variants PSGl, and the 
two others decribed before (PSG16 [26]; PSG-C [15]) were used as hybridization probes (Table 
I). The cDNA fragments from the 3’-untranslated region of PSGl, and the PSGl,-specific oligo- 
nucleotide both hybridized most strongly with the 2.2 kb and weakly with a 2.0 kb mRNA species 
in placenta (Fig 3A, lane 3 and Fig. 3B, lanes 3, 5). The cDNA probe cross-hybridized only 
under nonstringent conditions with the 2.8 kb NCA mRNA in colon tumor RNA (compare in 
Fig. 3B, lanes 4 and 6). On the other hand, the cDNA probe covering the 3’untranslated region 
of PSGl, hybridized strongly with a 2.0 kb and more weakly with a 2.5 kb mRNA species (Fig. 
3A lane 5). The latter indicates that an additional mRNA species exists, which is possibly trans- 
cribed from another PSG gene containing a PSGl,-like 3’-untranslated region. Therefore, the 2.2 
SPl 
12 34 56 
FIgurn 4: Expreaabn of PSCl, cDNA in mouse 3l3 cells. (A) The complete cDNA of clone PSGl, has been inserted 
dowweam of the SW0 early promoter into the EcoRI site of the eukaryotic qwession vector pBEH. ‘The coding 
region of PSGl, is indicat& Ly a filed-in arrow. (B) The resubing plasmid pBEH/PSGl was cotransfected with 
pSV2nea into 3T3 cells by lipofection. Stable G4l&esistant hansfeuants were labeled with [%]methionine. The media 
from transfectanta (lanes 3,4) or control transfectants without pBEH/PSGl, (lanes $6) were immunoprecipitated with 
rabbit anti-human SPl in the absence (lanes 3,5) or presence of an excess of pmi!ied SPl (=synonymow for WlG). 
The prwipiMe8 w&e anaIyM by ek%%mphwesis on a 10% SDS/potyaaylamMe gel and autwadiogmphed. Pmteins with 
the indicatul sized and SPl(2 rg) were used as markers after staining with coomassie blue. 
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kb mRNA corresponds to the PSGl, the 2.0 mRNA to the PSGl, splice variant. No hybridiza- 
tion signal was obtained with an oligonucleotide specific for PSG16 and PSG-C, respectively. The 
former oligonucleotide spans the site, where PSG16 differs from PSGl, by insertion of a 86 bp 
sequence at the end of R, in PSGl, (26). 
Expression of PSGl, cDNA in eukaryotic cells. As an initial step toward studying the bio- 
chemical properties and function of individual mature members of the complex PSG family, we 
have started to express PSGI, cDNA in mouse NIH3T3 cells. This was achieved by cloning the 
complete cDNA into the expression vector pBEH (39) under the control of the Simian Virus 40 
early promotor (Fig. 4A). The resulting plasmid pBEH/PSGl, was cotransfected into 3T3 cells 
1 so6 loo0 IS00 
CCM35 
PS#G-C 
PSGl. 
PSG 16 
PSG4 
NCA 
PSPG-E 
SP1-i 
FL.NCA-3 
CEA 
Ass WC 
I ?a 
C 
I I 
I 
Rs 
I 66 I i II 
F&we 5: CompadsUn of the 3’-untranslated regions of PSGs, CEA and NC-A cDNAs with the CGM35 gane. The 
nudeotide squenca compared begin with the last R, domain and continue to the 3’cnd of each gene or cDNA. 
Putative splice donor (f&d arrowheads) and splice acceptor sites (open arrowheads) are shown for the CGM35 gene 
(18). The single line adjoining the hvo blocks represents intron sequence. Homologous regions from mRNAs of other 
FSG/CEA-like gene% indicated hy identical shading am aligned as Modu below, who&y putative Uon borders are 
talrenintoaocount.PSGl,PSgGC,PSGl,endPSG16~~vsriantsolaKgg\e.C-GtamirrPldonuin,M 
=tllcmhranedomain,Alu -Alu-typerepstitiveclsmont.Polylc*ngLtioalita~indiattdtybldrvariorlbPn(due 
to high sequence homology to PS#GE, an idential po@daaylation site id assumed fez PL.-NCA-3). deWions largcx than 
20 nudeotidea by triangles. Arrows demarcate the ends of the observed Cl% mRNAs qecicd formed by alternative 
polyadenylation. Numbers in blocks show degrees of nucleotide sequmce similarity to corresponding regions of CGh435, 
numbers in brackets betwean individual cDNA species. The nudeotidc sequences used for this comparison were taken 
from the following references: PS#G, PQG-E (15). PSGM (26), NCA (lo), SPl-i (17), PL-NCA-3 (57), CEA (6.18). 
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together with pSV2neo, a plasmid which confers resistance toward the neomycin derivative 
G418. Pools of about 100 stable G418-resistant transfectants were labeled with $S]methionine. 
From the spent media of the cells transfected with pBEH/PSGl, a protein with an apparent M, 
of 66,000 could be precipitated with rabbit anti-human SPl (Fig. 4B, lane 3), being slightly 
smaller than the major component of purified SPl (lane 2). Addition of an excess of purified 
SPl abolished the precipitation of this radioactively labeled protein (Fig. 4B, lane 4). No protein 
could be precipitated from media of control 3T3 cells transfected with pSV2neo alone (Fig. 4B, 
lanes 5, 6). Similar transfection experiments with African green monkey cos cells yielded a 
slightly smaller protein with an M, of 65,000 (data not shown). 
DISCUSSION 
Our findings obtained by cDNA cloning indicate that at least three different genes of the PSG 
subgroup are transcribed in liver during fetal development (PSGl, PSG4 and PSG6), whereby 
for PSGl two splice variants are observed (PSGl, and PSGI,). These results together with 
observations by Barnett et al. (13) who identified BGP I transcripts in human fetal liver suggest 
that also other members of the CEA gene family apart from the CEA gene play a role during 
fetal development. However, for confirmation and quantitation of transcription of the PSG genes 
Northern analyses with RNA from fetal liver have to be performed. 
So far eight closely related PSG genes have been identified by isolation of genomic and cDNA 
clones (3,15-l&26,57 and results to be published elsewhere). cDNA clones with nearly identical 
nucleotide sequences as found in lambda PSGI,, have been isolated recently from human pla- 
centa (PSG93 [26]; PSj3G-D [15]; hPSPl1 [16]), fetal liver (FL-NCA-2 [57]) or testis libraries 
(lambda hPS3 [49]). Lambda PSGl, differs from FL-NCA-2 whose sequence is identical with 
PSG93 and hPSPl1 in 7 positions three of which are in the coding region. The latter differences 
all lead to amino acid substitutions. Comparison with the sequence of PSG93 reveals three 
different nucleotide exchanges which lead in one case to an amino acid change. These differen- 
ces probably reflect genetic polymorphisms. A cDNA clone corresponding to our lambda PSGl, 
has also been recently described by Khan et al. (19). Furthermore, the sequence of a partial 
cDNA clone from a HeLa cDNA library has been reported which is obviously derived from the 
same PSG gene as lambda PSG4 (hHSP2 [16]). The sequences of hHSP2 and lambda PSG4 
overlap for 138 bp. In this region they are identical except for the first 5 nucleotides of lambda 
PSG4 which is probably a cloning artefact. Together, they cover almost the complete coding se- 
quence, lacking the first three amino acids. The deduced domain structures of the PSG antigens, 
where known, are very similar. The PSGl, PSG4, PSG6 and SPl (17) proteins are composed of 
one variable or N-terminal domain (N) and three constant or half repeat domains (RA1, R,, 
R,), whereas other PSGs (FL-NCA3 [571, PSG-E [15]) lack the R,, or R, domain, respectively. 
The R, and R, domains are encoded by separate exons as has been shown before for the NCA 
gene (50) and the PSG gene CGM35 (18). Two pairs of exons coding for half repeat domains 
(R,,, R,, and R,, R,J are found in CGM35, whereby the splice acceptor signal at the R,, exon 
is mutated (18). This could explain the lack of R,, in the PSGs so far analysed or, in analogy, 
the absence of both the R,, and R, domain in PSPG-E (15) or R,, and R,, in FL-NCA3 (57). 
However, sequence analysis of a cosmid clone comprising the PSG4 gene reveals an intact splice 
acceptor consensus equence for the R,, exon (results to be published elsewhere). Therefore, 
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inclusion or exclusion of R,,B domains by differential splicing, as is found for the BGP 1 gene 
(13), has to be considered. 
The complexity of the protein family encoded by the PSG genes is increased by differential 
SpliCing. This is infered from the observation that the sequences of all PSGl mRNAs diverge at 
the end of R, (Fig. 2; [15,16]). Obviously, the same R,, exon is spliced to various exons which 
encode unrelated, 3-12 amino acid long C-terminal domains and 3’-untranslated regions (Fig. 5). 
These PSGl C-terminal domains as well as the ones found in PSG4 (5 amino acids) and PSG6 
(22 amino acids; Fig. 2) are very short and not particularly hydrophobic suggesting that these 
proteins are directly secreted and not membrane bound. This agrees well with the finding of 
large amounts of PSGs in maternal sera (28). However, presently it cannot be ruled out that the 
longer PSG C-terminal domains, especially that in PSG6, might serve as signals for glycosyl 
phosphatidylinositol membrane attachment as found for CEA (51-53) and NCA (54,55). In this 
case, the PSG6 protein which also contains the RGD sequence within its N-terminal domain 
could have a function in cell adhesion, as suggested for CEA (23). 
The two splice variants of PSGl which we have isolated from a fetal liver cDNA library, are also 
present in placenta, where two additional splice products have been found (15,26). PSGl, mRNA 
is readily detectable by hybridization with [‘PIlabeled oligonucleotide (Fig. 3A), whereas PSG16 
(26) and PSG-C (15) were not found under identical conditions. The PSGl, splice variant, 
therefore, seems to be one of the major transcripts of the PSGl gene in placenta. A similar 
complex splicing pattern can be expected to exist for other genes. From the nucleotide sequences 
of the CGM35 gene, transcription products similar to PSGl,, PSBG-C, PSGl, and PSG16 can be 
predicted ([18]; Fig. 5). In this gene, exons covering the various C-terminal domains and 3’-un- 
translated regions are clustered 3’ of the R,, exon. In fact, the region in CGM35 which encodes 
sequences homologous to the 3’-region of PSGI, is contiguous with the R,, exon and partially 
overlaps the exon encoding the C-terminal domain and the 3’-untranslated region of the 
PSBG-C-like mRNA species (Fig. 5). Sequences homologous to the 3’-noncoding region of 
PSGl, are also present in transcripts of other CEA-like genes and might be expected to be 
present in CGM35 and PSG mRNAs (Fig. 5 and see below). This could explain the cross-hybrid- 
ization of the PSGl, 3’-probe with a 2.5 kb mRNA (Fig. 3A). The observation of several mRNA 
species which hybridize with the PSG4-specific oligonucleotide also suggests differential splicing 
for the PSG4 gene (Fig. 3B), whereby the lambda PSG4 clone corresponds to the PSGl, splice 
variant. Due to the high degree of similarity between CGM35, PSGl, and PSG4 and the conser- 
vation of the splice acceptor signal for the generation of the PSG16-like splice variant (Fig. 5), 
the existence of mRNA species homologous to PSGl,, PSBG-C and PSG16 can be predicted. No 
sequence similarity between the C-terminal domain and 3’-untranslated region of PSG6 and the 
corresponding region of the CGM35 gene was found. However, the homologous exon may be 
located further downstream of the known CGM35 genomic sequence. 
It is interesting to note that sequences homologous to the 3’-regions of the PSG genes are also 
found in more distantly related genes of the CEA subgroup. For example the first 430 bp of the 
presumed 3’-region-exons of PSGl, and PSG4 show about 80% similarity to the first 430 bp of 
the 3’-untranslated region of NCA mRNA downstream of the point of complete divergence 
between CEA and NCA mRNA (10; Fig. 5). This explains the observed cross-hybridization 
under low stringency conditions between PSGl, and NCA mRNA (Fig. 3A lane 7 and Fig 3B 
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lane 4). Furthermore, a rather high similarity is found for the 3’-untranslated region of CEA and 
those of PSGl,, PSj3G-C, PSBG-E, SPl-i and FL-NCA3 mRNA (Fig. 5). Closer sequence 
analyses revealed that the similarity with the CEA 3’untranslated region stops abruptly in PSGl, 
and correspondingly in CGM35 upstream of position 1391. In the closely related 3’noncoding 
regions of PS/?G-E, SPl-i and FL-NCA3 mRNAs, however the similarity continues beyond this 
point up to the stop codon of these PSG mRNAs and CEA mRNA (Fig. 5). In the CEA gene 
the hydrophobic membrane (M) domain together with 39 nucleotides of the 3’-untranslated 
region, are encoded in a separate exon (Fig. 5 and results to be published elsewhere). Based on 
these data, it can be hypothesized that the C-terminal domain and a small part of the 3’-untrans- 
lated region of PSBG-E, SPl-i and FL-NCA3 are also encoded by separate exons. This idea is 
supported by the observation that a deletion of 67 nucleotides is found in PSBG-E and 
FL-NCA3 mRNA ending exactly at the hypothetical C-terminal domain exon border (Fig. 5). 
This deletion is possibly caused by alternative splicing within the 3’-untranslated region exon. 
This explanation is supported by the presence of a splice acceptor consensus equence in SPl-i 
mRNA at a position where the deletion ends in PSBG-E and FL-NCA3 mRNA (Fig. 5). The 
putative C-terminal domain exon together with the surrounding intron sequences are obviously 
deleted in the CGM35 gene and in analogy in the PSGl and PSG4 genes. This notion is stressed 
by the finding that in the gene corresponding to FL-NCA3 which we have recently isolated, the 
sequences downstream of the R,, exon share similarity with PSGI, and CGM35 exactly up to the 
position where the similarity with the CEA 3’untranslated region begins (see Fig. 5; results to 
be published elsewhere). In conclusion, the similarities in the 3’-untranslated regions among the 
various members of the CEA gene family imply, that during evolution the exons containing the 
3’-untranslated regions have been co-amplified together with the coding exons. Relatively late in 
evolution, i.e. after separation of the CEA and PSG subgroups, but before the appearance of the 
closely related PSGl, PSG4 and CGM35 genes, the deletion of the putative C-terminal exon and 
finally the insertion of the two Am-like repetitive sequences into the CEA gene must have 
occurred. 
Six of the eight PSG genes have been tested and shown to be transcriptionally active by 
Northern blot analyses and by cDNA cloning. Five of these genes are transcribed in placenta 
(Fig. 3 and unpublished results). Together with the proteins encoded by the PSGl splice vari- 
ants, at least eight very similar PSGs are expected to be synthesized in placenta. This complexity 
of PSG antigens is higher than anticipated from protein analyses, which identified three PSGs of 
72, 64 and 54 kD (26). Because of the high degree of glycosylation of these antigens a direct 
assignment on the basis of their deduced primary sequence cannot be made. We, therefore, 
started to individually express PSG cDNAs in cells which do not express immunologically cross- 
reacting antigens. With a M, of 66 kD, the PSGl, antigen was found to have a similar size to the 
major product of the placental PSG preparation (Fig. 4B). In similar experiments using the 
human HeLa cell line for transfection the size of the nearly identical FL-NCA-1 protein which 
corresponds to PSGl, was found to be 72 kD (19). As we expect many of the closely related 
PSG genes to code for antigens of similar size, these separately expressed, glycosylated antigens 
have to be further characterized. This might be achieved with monoclonal antibodies or, alterna- 
tively, with polyclonal antisera directed against peptide epitopes, specific for the various anti- 
gens. In conclusion, determination of the structure of all PSG genes and their splice variants, 
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together with assignment of the various genes to their respective proteins, will be a prerequisite 
to studying the function of individual PSGs. 
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